Safety and Efficacy of COVID-19 Vaccines Among Patients with Multiple Sclerosis: Letter to Editor

Int J Prev Med. 2024 Sep 28:15:45. doi: 10.4103/ijpvm.ijpvm_11_24. eCollection 2024.

Authors

Omid Mirmosayyeb^{1

2}, Elham Moases Ghaffary¹, Aram Zabeti³, Vahid Shaygannejad^{1

2}

Affiliations

¹ Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
² Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
³ Department Neurology, University of Cincinnati, Cincinnati, OH, USA.

No abstract available